<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Purdue Pharma LP — New Patents | PatentBrief</title>
    <link>https://patentbrief.org/company/purdue-pharma-lp</link>
    <description>Plain-English explanations of patents assigned to Purdue Pharma LP, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 15 Jun 2026 05:53:39 GMT</lastBuildDate>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://patentbrief.org/company/purdue-pharma-lp/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Using Antibodies to Target Tissue Factor Without Stopping Blood Clotting</title>
      <link>https://patentbrief.org/patent/us/7993644/stelara-ustekinumab</link>
      <description>A patent describing specific antibodies that attach to a protein called tissue factor without interfering with the body&apos;s natural blood-clotting process.</description>
      <pubDate>Tue, 09 Aug 2011 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://patentbrief.org/patent/us/7993644/stelara-ustekinumab</guid>
    </item>
  </channel>
</rss>
